Verona Pharma plc (VRNA) Reports In-Line Q3 EPS

Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Jaguar Health (JAGX) files for 41M share offering by selling stockholders
• Blackstone, Donerail among final bidders for MarineMax - Reuters